[SYRS] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
07-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- 2.88%
YoY- -5.08%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 5,162 3,188 462 375 0 0 317 59.13%
PBT -22,490 -17,196 -19,455 -14,047 -13,368 -12,021 -6,097 24.27%
Tax 969 0 0 0 0 0 0 -
NP -22,490 -17,196 -19,455 -14,047 -13,368 -12,021 -6,097 24.27%
Tax Rate - - - - - - - -
Total Cost 27,652 20,384 19,917 14,422 13,368 12,021 6,414 27.54%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin -435.68 -539.40 -4,211.04 -3,745.87 0.00 0.00 -1,923.34 -21.90%
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -3.60 -3.76 -4.67 -4.27 -5.23 -47.08 -23.88 -27.02%
EPS Diluted -3.58 -3.76 -4.67 -4.27 -5.23 -47.08 -23.88 -27.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.